---
schema_version: "secwatch.filing_event.v1"
accession: "0001477932-22-000348"
form_type: "8-K"
ticker: "BICX"
cik: "0001443863"
company_name: "BioCorRx Inc."
filed_at: "2022-01-19T23:59:59+00:00"
generated_at: "2026-06-27T17:10:20.768523+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioCorRx raises $1M via private placement of 229,886 shares at $4.35/share to two directors

## Summary
- Gross proceeds of $1M from sale of 229,886 shares at $4.35 per share to Lucido and Galligan trusts.
- Both investors are BioCorRx board members; Louis Lucido and Joseph Galligan are the trustees.
- Use of proceeds: 48% for legal fees from Buchalter; 52% for general working capital and administration.
- Agreements became effective on January 12 (Lucido) and January 19 (Galligan) upon cash payment.
- Shares are restricted securities issued under Rule 506 of Regulation D and bear appropriate legends.

## SEC filing metadata
- accession: 0001477932-22-000348
- form_type: 8-K
- ticker: BICX
- cik: 0001443863
- company_name: BioCorRx Inc.
- filed_at: 2022-01-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1443863/000147793222000348/0001477932-22-000348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1443863/000147793222000348/bicx_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001477932-22-000348
- JSON: https://secwatch.observer/filing/0001477932-22-000348.json
- Plain text: https://secwatch.observer/filing/0001477932-22-000348.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.